Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Atlanta, Georgia


Purpose:

The study is to evaluate the effect of bifeprunox on the pharmacokinetics of valproate in subjects with Bipolar I Disorder after multiple dose administration.


Criteria:

Inclusion Criteria: - Males or females - 18-65 years old - meeting DSM-IV criteria for Bipolar I Disorder, either manic or mixed episodes, with or without psychotic features Exclusion Criteria: - subjects who are acutely manic, acutely depressed, psychotic or subjects with a current Axis I primary psychiatric diagnosis other than Bipolar I Disorder based on DSM-IV TR criteria.


NCT ID:

NCT00141505


Primary Contact:

Study Director
Global Clinical Director Solvay
Solvay Pharmaceuticals


Backup Contact:

N/A


Location Contact:

Atlanta, Georgia
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: June 25, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.